These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11792710)

  • 21. Design and in silico screening of combinatorial library of antimalarial analogs of triclosan inhibiting Plasmodium falciparum enoyl-acyl carrier protein reductase.
    Frecer V; Megnassan E; Miertus S
    Eur J Med Chem; 2009 Jul; 44(7):3009-19. PubMed ID: 19217192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the interaction energies for the binding of hydroxydiphenyl ethers to enoyl-acyl carrier protein reductases.
    Muralidharan J; Suguna K; Surolia A; Surolia N
    J Biomol Struct Dyn; 2003 Feb; 20(4):589-94. PubMed ID: 12529157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors.
    Kapoor M; Dar MJ; Surolia A; Surolia N
    Biochem Biophys Res Commun; 2001 Dec; 289(4):832-7. PubMed ID: 11735121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis.
    Hoang TT; Schweizer HP
    J Bacteriol; 1999 Sep; 181(17):5489-97. PubMed ID: 10464225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, development, synthesis, and docking analysis of 2'-substituted triclosan analogs as inhibitors for Plasmodium falciparum enoyl-ACP reductase.
    Kapoor N; Banerjee T; Babu P; Maity K; Surolia N; Surolia A
    IUBMB Life; 2009 Nov; 61(11):1083-91. PubMed ID: 19859979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.
    Shah P; Siddiqi MI
    SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prioritization of active antimalarials using structural interaction profile of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR)-triclosan derivatives.
    Kumar SP; George LB; Jasrai YT; Pandya HA
    SAR QSAR Environ Res; 2015; 26(1):61-77. PubMed ID: 25567142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Slow-tight-binding inhibition of enoyl-acyl carrier protein reductase from Plasmodium falciparum by triclosan.
    Kapoor M; Reddy CC; Krishnasastry MV; Surolia N; Surolia A
    Biochem J; 2004 Aug; 381(Pt 3):719-24. PubMed ID: 15086316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paradigm shifts in malaria parasite biochemistry and anti-malarial chemotherapy.
    Surolia N; RamachandraRao SP; Surolia A
    Bioessays; 2002 Feb; 24(2):192-6. PubMed ID: 11835284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of triclosan inhibition of bacterial fatty acid synthesis.
    Heath RJ; Rubin JR; Holland DR; Zhang E; Snow ME; Rock CO
    J Biol Chem; 1999 Apr; 274(16):11110-4. PubMed ID: 10196195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I.
    McLeod R; Muench SP; Rafferty JB; Kyle DE; Mui EJ; Kirisits MJ; Mack DG; Roberts CW; Samuel BU; Lyons RE; Dorris M; Milhous WK; Rice DW
    Int J Parasitol; 2001 Feb; 31(2):109-13. PubMed ID: 11239932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene.
    Heath RJ; Li J; Roland GE; Rock CO
    J Biol Chem; 2000 Feb; 275(7):4654-9. PubMed ID: 10671494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum.
    Surolia N; Surolia A
    Nat Med; 2001 Feb; 7(2):167-73. PubMed ID: 11175846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase.
    Kumar G; Parasuraman P; Sharma SK; Banerjee T; Karmodiya K; Surolia N; Surolia A
    J Med Chem; 2007 May; 50(11):2665-75. PubMed ID: 17477517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.
    Tallorin LC; Durrant JD; Nguyen QG; McCammon JA; Burkart MD
    Bioorg Med Chem; 2014 Nov; 22(21):6053-6061. PubMed ID: 25284249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigallocatechin gallate is a slow-tight binding inhibitor of enoyl-ACP reductase from Plasmodium falciparum.
    Banerjee T; Sharma SK; Surolia N; Surolia A
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1238-42. PubMed ID: 18992222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural basis and mechanism of enoyl reductase inhibition by triclosan.
    Stewart MJ; Parikh S; Xiao G; Tonge PJ; Kisker C
    J Mol Biol; 1999 Jul; 290(4):859-65. PubMed ID: 10398587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitor binding studies on enoyl reductase reveal conformational changes related to substrate recognition.
    Roujeinikova A; Sedelnikova S; de Boer GJ; Stuitje AR; Slabas AR; Rafferty JB; Rice DW
    J Biol Chem; 1999 Oct; 274(43):30811-7. PubMed ID: 10521472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of the Francisella tularensis enoyl-acyl carrier protein reductase (FabI) in complex with NAD(+) and triclosan.
    Mehboob S; Truong K; Santarsiero BD; Johnson ME
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Nov; 66(Pt 11):1436-40. PubMed ID: 21045289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan.
    Ward WH; Holdgate GA; Rowsell S; McLean EG; Pauptit RA; Clayton E; Nichols WW; Colls JG; Minshull CA; Jude DA; Mistry A; Timms D; Camble R; Hales NJ; Britton CJ; Taylor IW
    Biochemistry; 1999 Sep; 38(38):12514-25. PubMed ID: 10493822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.